Search by Drug Name or NDC
NDC 51754-4200-04 Akovaz 50 mg/mL Details
Akovaz 50 mg/mL
Akovaz is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is EPHEDRINE SULFATE.
Product Information
| NDC | 51754-4200 |
|---|---|
| Product ID | 51754-4200_5a627a89-7997-4af5-a1d0-2cedbe1bc868 |
| Associated GPIs | 38000030102015 |
| GCN Sequence Number | 076091 |
| GCN Sequence Number Description | ephedrine sulfate VIAL 50MG/ML(1) INTRAVEN |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 41364 |
| HICL Sequence Number | 002084 |
| HICL Sequence Number Description | EPHEDRINE SULFATE |
| Brand/Generic | Brand |
| Proprietary Name | Akovaz |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ephedrine sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPHEDRINE SULFATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208289 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-4200-04 (51754420004)
| NDC Package Code | 51754-4200-4 |
|---|---|
| Billing NDC | 51754420004 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (51754-4200-4) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2021-04-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |